MDxHealth (MDXH) Competitors $2.26 +0.10 (+4.63%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MDXH vs. OPGN, BGLC, FRES, ACON, NTRA, LH, DGX, EXAS, RDNT, and GHShould you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include OpGen (OPGN), BioNexus Gene Lab (BGLC), Fresh2 Group (FRES), Aclarion (ACON), Natera (NTRA), Laboratory Co. of America (LH), Quest Diagnostics (DGX), Exact Sciences (EXAS), RadNet (RDNT), and Guardant Health (GH). These companies are all part of the "medical laboratories" industry. MDxHealth vs. OpGen BioNexus Gene Lab Fresh2 Group Aclarion Natera Laboratory Co. of America Quest Diagnostics Exact Sciences RadNet Guardant Health OpGen (NASDAQ:OPGN) and MDxHealth (NASDAQ:MDXH) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability, institutional ownership and community ranking. Which has better earnings & valuation, OPGN or MDXH? OpGen has higher earnings, but lower revenue than MDxHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOpGen$2.67M2.26-$32.67MN/AN/AMDxHealth$70.19MN/A-$43.10M-$1.52-1.49 Does the media favor OPGN or MDXH? In the previous week, OpGen and OpGen both had 1 articles in the media. OpGen's average media sentiment score of 0.00 equaled MDxHealth'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OpGen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MDxHealth 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in OPGN or MDXH? 2.7% of OpGen shares are owned by institutional investors. 43.8% of OpGen shares are owned by insiders. Comparatively, 1.7% of MDxHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, OPGN or MDXH? OpGen has a beta of -0.62, suggesting that its share price is 162% less volatile than the S&P 500. Comparatively, MDxHealth has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Does the MarketBeat Community favor OPGN or MDXH? OpGen received 286 more outperform votes than MDxHealth when rated by MarketBeat users. However, 55.56% of users gave MDxHealth an outperform vote while only 53.56% of users gave OpGen an outperform vote. CompanyUnderperformOutperformOpGenOutperform Votes30153.56% Underperform Votes26146.44% MDxHealthOutperform Votes1555.56% Underperform Votes1244.44% Do analysts rate OPGN or MDXH? MDxHealth has a consensus price target of $7.00, indicating a potential upside of 209.73%. Given MDxHealth's stronger consensus rating and higher probable upside, analysts plainly believe MDxHealth is more favorable than OpGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OpGen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00MDxHealth 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is OPGN or MDXH more profitable? MDxHealth has a net margin of -49.52% compared to OpGen's net margin of -1,140.36%. OpGen's return on equity of 0.00% beat MDxHealth's return on equity.Company Net Margins Return on Equity Return on Assets OpGen-1,140.36% N/A -287.58% MDxHealth -49.52%-1,077.84%-28.82% SummaryMDxHealth beats OpGen on 8 of the 13 factors compared between the two stocks. Ad Stansberry Research2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisisDan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. Get MDxHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDXH vs. The Competition Export to ExcelMetricMDxHealthMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.93B$5.13B$9.07BDividend YieldN/A15.63%4.93%4.23%P/E Ratio-1.4916.0289.7417.19Price / SalesN/A284.461,115.29116.95Price / CashN/A472.1142.8237.86Price / Book0.495.194.774.78Net Income-$43.10M-$32.86M$120.04M$225.60M7 Day Performance-5.83%-3.01%-1.92%-1.23%1 Month Performance32.16%2.96%11.46%3.36%1 Year Performance-93.86%12.37%30.52%16.60% MDxHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDXHMDxHealth1.8979 of 5 stars$2.26+4.6%$7.00+209.7%-93.9%$0.00$70.19M-1.49300News CoverageOPGNOpGenN/A$1.07-3.6%N/A-82.7%$8.95M$3.42M0.00100Analyst ForecastNews CoverageGap DownBGLCBioNexus Gene LabN/A$0.25-3.6%N/A-59.5%$4.51M$9.26M0.0030Positive NewsGap UpFRESFresh2 GroupN/A$1.28-1.5%N/A-86.8%$1.15M$16.98M0.0075Positive NewsGap DownACONAclarion1.8597 of 5 stars$0.10-1.7%$1.30+1,159.7%-97.0%$1.08M$49,289.000.007Gap DownNTRANatera2.0775 of 5 stars$168.80+1.4%$152.67-9.6%+168.5%$22.29B$1.53B-94.633,293Positive NewsGap DownLHLaboratory Co. of America4.9652 of 5 stars$230.68-0.6%$257.67+11.7%+2.9%$19.29B$12.71B44.8867,000Analyst ForecastPositive NewsDGXQuest Diagnostics4.9245 of 5 stars$153.08-1.2%$168.92+10.3%+12.5%$17.09B$9.54B20.8348,000Analyst UpgradeEXASExact Sciences4.4883 of 5 stars$60.54-1.2%$72.94+20.5%-16.8%$11.34B$2.69B-51.746,600RDNTRadNet3.8822 of 5 stars$78.00-0.4%$84.75+8.7%+106.8%$5.77B$1.77B-1,119.1410,288Positive NewsGHGuardant Health4.1203 of 5 stars$35.46+2.0%$40.60+14.5%+16.0%$4.38B$692.26M-8.201,779 Related Companies and Tools Related Companies OPGN Competitors BGLC Competitors FRES Competitors ACON Competitors NTRA Competitors LH Competitors DGX Competitors EXAS Competitors RDNT Competitors GH Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MDXH) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MDxHealth SA Please log in to your account or sign up in order to add this asset to your watchlist. Share MDxHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDXH Stock Alerts